进行性多灶性白质脑病临床诊治研究进展
Advances in Clinical Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy
DOI: 10.12677/acm.2026.1631060, PDF,   
作者: 董昊雯:暨南大学附属第一医院神经内科,广东 广州;申 杰*:暨南大学第一临床医学院,广东 广州;深圳市龙岗区第三人民医院神经内科,广东 深圳
关键词: 进行性多灶性白质脑病JC病毒免疫抑制免疫重建炎症综合征Progressive Multifocal Leukoencephalopathy (PML) John Cunningham Virus (JVC) Immunosuppression Immune Reconstitution Inflammatory Syndrome (IRIS)
摘要: 进行性多灶性白质脑病是一种由JC病毒感染少突胶质细胞引发的罕见的神经脱髓鞘疾病,主要发生于免疫功能严重受损的个体。随着免疫抑制剂广泛应用及HIV/AIDS流行,近年来其发病率显著上升。目前,该疾病的发病机制、诊断及治疗方面仍面临诸多挑战,如早期诊断困难、缺乏特效疗法等。本文系统综述进行性多灶性白质脑病的流行病学、发病机制、临床表现、诊断策略及治疗进展。重点探讨免疫重建综合征、新型生物标志物、影像学技术革新以及靶向与免疫疗法的最新研究成果,以期为临床诊疗提供全面参考,并展望未来研究方向。
Abstract: Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating neurological disorder caused by JC virus infection of oligodendrocytes, predominantly occurring in individuals with severe immunosuppression. With the widespread use of immunosuppressants and the prevalence of HIV/AIDS, the incidence of PML has increased significantly in recent years. Currently, the pathogenesis, diagnosis, and treatment of PML pose substantial challenges, including difficulties in early detection and the absence of specific therapeutic agents. This article systematically reviews the epidemiology, pathogenesis, clinical manifestations, diagnostic strategies, and therapeutic advances in PML. It focuses specifically on recent research developments concerning immune reconstitution syndrome, novel biomarkers, advances in imaging modalities, as well as targeted and immunotherapeutic approaches. This review aims to provide a comprehensive reference for clinical management and to outline directions for future research.
文章引用:董昊雯, 申杰. 进行性多灶性白质脑病临床诊治研究进展[J]. 临床医学进展, 2026, 16(3): 2598-2605. https://doi.org/10.12677/acm.2026.1631060

参考文献

[1] Jancar, N., Sousa Gonçalves, F., Duro, J., Lessa Simões, M. and Aguiar, P. (2022) Progressive Multifocal Leukoencephalopathy in a Chemotherapy-Naive Patient with Chronic Lymphocytic Leukemia: A Case Report. Cureus, 14, e32912. [Google Scholar] [CrossRef] [PubMed]
[2] Rocchi, A., Sariyer, I.K. and Berger, J.R. (2023) Revisiting JC Virus and Progressive Multifocal Leukoencephalopathy. Journal of NeuroVirology, 29, 524-537. [Google Scholar] [CrossRef] [PubMed]
[3] Glenn, T., Berger, J.R. and McEntire, C.R.S. (2025) Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Frontiers in Neurology, 16, Article 1575653. [Google Scholar] [CrossRef] [PubMed]
[4] Arora, S., Ahmad, F.M.H., Deshwal, R. and Behal, P. (2022) Study of Clinical Profile and Outcomes in Progressive Multifocal Leukoencephalopathy in Acquired Immunodeficiency Syndrome Patients in the Highly Active Antiretroviral Therapy Era—An Observational Study. Indian Journal of Sexually Transmitted Diseases and AIDS, 43, 156-160. [Google Scholar] [CrossRef] [PubMed]
[5] Gomathy, S., Panigrahi, B., Tirlangi, P.K., Wig, N., Brijwal, M., Sharma, M.C., et al. (2022) Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus and Autoimmune Hepatitis. International Journal of Rheumatic Diseases, 25, 705-713. [Google Scholar] [CrossRef] [PubMed]
[6] Okazaki, T., Kodama, D., Yamadera, M., Sugiyama, Y., Tsuji, H., Nishida, F., et al. (2021) Progressive Multifocal Leukoencephalopathy in a Patient with Rheumatoid Arthritis under Salazosulfapyridine Treatment. Rinsho Shinkeigaku, 61, 833-838. [Google Scholar] [CrossRef] [PubMed]
[7] Hoeynck, B.W., Cohen, A.D., Stadtmauer, E.A., Susanibar-Adaniya, S.P., Vogl, D.T., Waxman, A.J., et al. (2023) Progressive Multifocal Leukoencephalopathy in Multiple Myeloma. European Journal of Haematology, 110, 322-329. [Google Scholar] [CrossRef] [PubMed]
[8] Meylor, J., Artunduaga, D.C., Mendoza, M., Hooshmand, S.I. and Obeidat, A.Z. (2024) Progressive Multifocal Leukoencephalopathy in Patients with Chronic Kidney Disease. Neurological Sciences, 45, 1619-1624. [Google Scholar] [CrossRef] [PubMed]
[9] Naydovich, L., Berger, J.R. and Milutinovic, P.S. (2025) Progressive Multifocal Leukoencephalopathy in a Young Adult with DOCK8 Deficiency: A Case of JC Virus Reactivation in Primary Immunodeficiency. Journal of NeuroVirology, 31, 585-587. [Google Scholar] [CrossRef
[10] Del Valle, L. and Khalili, K. (2021) Induction of Brain Tumors by the Archetype Strain of Human Neurotropic JCPyV in a Transgenic Mouse Model. Viruses, 13, Article 162. [Google Scholar] [CrossRef] [PubMed]
[11] Harypursat, V., Zhou, Y., Tang, S. and Chen, Y. (2020) JC Polyomavirus, Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome: A Review. AIDS Research and Therapy, 17, Article No. 37. [Google Scholar] [CrossRef] [PubMed]
[12] Santana, M.N., Ferrari, R., Macedo, A.C., Marcusso, R.M.N., Fernandes, R.D.A. and Vidal, J.E. (2023) Acquired Immunodeficiency Syndrome-Related Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome: Prevalence, Main Characteristics, and Outcomes in a Brazilian Center. Arquivos de Neuro-Psiquiatria, 81, 883-890. [Google Scholar] [CrossRef] [PubMed]
[13] Kim, R.B., Irani, D.N. and Kim, J. (2023) Progressive Multifocal Leukoencephalopathy Selectively Affecting Broca’s and Wernicke’s Areas in an Immunocompetent Patient: A Case Report. Radiology Case Reports, 18, 1334-1336. [Google Scholar] [CrossRef] [PubMed]
[14] Waqas, S., Iqbal, U., Khurram, L., Saleem, A., Ain, Q.U., Butt, M.A., et al. (2025) Rapid Onset of Neurological Symptoms in an HIV-Positive Patient with Progressive Multifocal Leukoencephalopathy: A Case Report. Annals of Medicine & Surgery, 87, 3994-3998. [Google Scholar] [CrossRef] [PubMed]
[15] Mori, K., Kurokawa, M., Harada, M., Nakamichi, K., Arai, H., Takao, M., et al. (2025) Overview of MRI Findings in Progressive Multifocal Leukoencephalopathy. Japanese Journal of Radiology, 43, 1908-1925. [Google Scholar] [CrossRef] [PubMed]
[16] Breville, G., Koralnik, I.J. and Lalive, P.H. (2021) Brainstem Progressive Multifocal Leukoencephalopathy. European Journal of Neurology, 28, 1016-1021. [Google Scholar] [CrossRef] [PubMed]
[17] Gone, J., Fontaine, T. and Kumar, G. (2024) A Rare Case of Progressive Multifocal Leukoencephalopathy. Radiology Case Reports, 19, 4654-4658. [Google Scholar] [CrossRef] [PubMed]
[18] Adapa, S., Jagdale, N., Vutukuru, K.K., Kondapalli, M.P. and Agarwal, S. (2024) Atypical Presentation of a Patient with Progressive Multifocal Leukoencephalopathy. Cureus, 16, e62545. [Google Scholar] [CrossRef] [PubMed]
[19] Avasarala, J. and Gangadhara, S. (2025) JC Virus PCR Assay Reporting for PML: Promises, Perils, and Pitfalls. Journal of Neurology, 272, Article No. 703. [Google Scholar] [CrossRef
[20] Boumaza, X., Bonneau, B., Roos-Weil, D., Pinnetti, C., Rauer, S., Nitsch, L., et al. (2022) Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors. Annals of Neurology, 93, 257-270. [Google Scholar] [CrossRef] [PubMed]
[21] Solis, M., Guffroy, A., Lersy, F., Soulier, E., Gallais, F., Renaud, M., et al. (2020) Inadequate Immune Humoral Response against JC Virus in Progressive Multifocal Leukoencephalopathy Non-survivors. Viruses, 12, Article 1380. [Google Scholar] [CrossRef] [PubMed]
[22] Kitazaki, Y., Iwasaki, H., Kitai, R., et al. (2020) Progressive Multifocal Leukoencephalopathy Associated with HIV Infection Diagnosed by Brain Biopsy with Repeated Negative PCR Testing of CSF JC Virus DNA. Brain and Nerve, 72, 541-546.
[23] Takahashi, K., Sato, Y., Hasegawa, H., Katano, H. and Suzuki, T. (2025) Histomorphological Variations in Progressive Multifocal Leukoencephalopathy Correlated with JCV Replication in Brain Lesions: Insights from 91 Patients. Acta Neuropathologica Communications, 13, Article No. 106. [Google Scholar] [CrossRef] [PubMed]
[24] Kuls-Oszmaniec, A., Nagańska, A., Kowalski, J., Cholewińska, G., Leńska-Mieciek, M. and Fiszer, U. (2025) Progressive Multifocal Leukoencephalopathy as a Rare First Manifestation of AIDS: Case Report. Postępy Psychiatrii i Neurologii, 34, 207-215. [Google Scholar] [CrossRef
[25] Naro, A., Billeri, L., Lauria, P., et al. (2022) Toward Improving Functional Recovery in AIDS-Associated Progressive Multifocal Leukoencephalopathy: A Single Case Pilot Study on a Novel Neuromodulation Approach. Innovations in Clinical Neuroscience, 19, 15-18.
[26] Okamoto, K., Takeda, A., Hatsuta, H., Sano, T., Takao, M., Ohsawa, M., et al. (2023) An Autopsy Case of Progressive Multifocal Leukoencephalopathy with Massive Iron Deposition in Juxtacortical Lesions. Neuropathology, 43, 396-402. [Google Scholar] [CrossRef] [PubMed]
[27] Sandberg, A.L., Bond, A.C.S., Bennett, L.J., Craig, S.E., Winski, D.P., Kirkby, L.C., et al. (2024) GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection. Viruses, 16, Article 1559. [Google Scholar] [CrossRef] [PubMed]
[28] Nay, S., Möhn, N., Grote-Levi, L., Bonifacius, A., Saßmann, M.L., Karacondi, K., et al. (2024) Combined Treatment with Allogeneic Epstein-Barr-and Human Polyomavirus 1 Specific T-Cells in Progressive Multifocal Leukoencephalopathy and EBV Infection: A Case Report. Therapeutic Advances in Neurological Disorders, 17. [Google Scholar] [CrossRef] [PubMed]
[29] Möhn, N., Wattjes, M.P., Adams, O., Nay, S., Tkachenko, D., Salge, F., et al. (2021) PD-1-Inhibitor Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy. Therapeutic Advances in Neurological Disorders, 14. [Google Scholar] [CrossRef] [PubMed]
[30] Mandelli, B., Mazzarella, R., Corbingi, A., Barbera, E.O.L., Perrone, S., Fanciullo, D., et al. (2025) The Role of the Immune System in Progressive Multifocal Leukoencephalopathy: A Comparative Analysis of Two Cases Following Autologous and Allogeneic Hematopoietic Stem Cell Transplantation. Annals of Hematology, 104, 3505-3510. [Google Scholar] [CrossRef] [PubMed]
[31] Nazneen, K.S., Mascarenhas, N., Elsheikh, E., Rezwanuzzaman, S. and Kumar, S. (2025) A Case Report of Progressive Multifocal Leukoencephalopathy (PML) in an Immunocompetent Patient. Cureus, 17, e91491. [Google Scholar] [CrossRef